ArticlePediatrics2026
Comparison of Cervical Spine Injury Prediction Rule Across Ages.
Article in Pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
objectiveTo evaluate the performance of the Pediatric Emergency Care Applied Research Network (PECARN) cervical spine injury (CSI) prediction rule among different pediatric age groups and derive and assess age-specific CSI prediction rules.
methodsWe conducted a planned secondary analysis of the PECARN CSI study of children younger than 18 years with known or suspected blunt trauma evaluated at 1 of 18 children's hospitals' emergency departments. Participants were divided into 4 clinically relevant age groups (<2, 2-7, 8-15, and 16 to <18 years). Age-specific rules were derived from the 4 high-risk predictors of the PECARN CSI Prediction Rule and using a classification and regression tree (CART) analysis to identify additional non-negligible age-specific risk factors. Rule performance was assessed using sensitivity, specificity, and positive and negative predictive values (NPVs) for each age group.
resultsThere were 22 430 participants included in analysis. Three to 8 risk factors were identified as non-negligible risk in CART analysis for each age-specific rule. The sensitivity of the PECARN CSI Prediction Rule (range 91.7%-94.4% across age groups) was similar to age-specific rules (range 88.4%-97.5%). The specificity of the PECARN CSI Prediction Rule (range 44.6%-72.3% for age groups) was also similar to age-specific rules (range 45.9%-75.9%). NPVs (all ≥99.6%) were similar across age groups for all rules.
conclusionsRule performance for the age-specific CSI prediction rules and the PECARN CSI Prediction Rule were similar. These findings support clinicians' use of the PECARN CSI Prediction Rule across the pediatric age spectrum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.